Evidence map›Paper›PMID 38938828›Full record

ArticleJACC. Advances2024

Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy.

Alessio Gasperetti, Richard Carrick, Alexandros Protonotarios, Mikael Laredo, Iris van der Schaaf, Petros Syrris, Brittney Murray, Crystal Tichnell, Chiara Cappelletto, Marta Gigli and 36 more

Abstract read
In one paragraph

Article in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.medRxiv : the preprint server for health sciences · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Lifetime cumulative activity burden is associated with symptomatic heart failure and arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy: a retrospective cohort study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Alessio GasperettiDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Richard CarrickDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Alexandros ProtonotariosDepartment of Cardiology, UCL Institute of Cardiovascular Science, London, United Kingdom.
Mikael LaredoAP-HP, IHU-ICAN, Groupe Hospitalier Pitié-Salpêtrière, Institut de Cardiologie, Sorbonne Université, Paris, France.
Iris van der SchaafDivision of Cardiology, Department of Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Petros SyrrisDepartment of Cardiology, UCL Institute of Cardiovascular Science, London, United Kingdom.
Brittney MurrayDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Crystal TichnellDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Chiara CappellettoDivision of Cardiology, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Marta GigliDivision of Cardiology, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Kristen MedoUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Peter CrabtreeDepartment of Cardiology, UCL Institute of Cardiovascular Science, London, United Kingdom.
Ardan M SagunerArrhythmia Unit, Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
Firat DuruArrhythmia Unit, Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
Robyn HylindCenter for Cardiovascular Genetics, Boston Children's Hospital and Harvard Medical School, Boston Children's Hospital Inherited Cardiac Arrhythmia Program, Boston, Massachusetts, USA.
Dominic AbramsCenter for Cardiovascular Genetics, Boston Children's Hospital and Harvard Medical School, Boston Children's Hospital Inherited Cardiac Arrhythmia Program, Boston, Massachusetts, USA.
Neal K LakdawalaDepartment of Cardiology, Brigham and Women's Hospital Cardiovascular Medicine, Boston, Massachusetts, USA.
Charles MassieCardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
Julia Cadrin-TourignyCardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
Mattia TargettiDepartment of Experimental and Clinical Medicine, Meyer Children Hospital and Careggi University Hospital, University of Florence, Florence, Italy.
Iacopo OlivottoDepartment of Experimental and Clinical Medicine, Meyer Children Hospital and Careggi University Hospital, University of Florence, Florence, Italy.
Maddalena GraziosiCardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Moniek CoxDepartment of Cardiology, University Medical Centre Groningen, Groningen, the Netherlands.
Elena BiaginiCardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Philippe CharronAP-HP, IHU-ICAN, Groupe Hospitalier Pitié-Salpêtrière, Institut de Cardiologie, Sorbonne Université, Paris, France.
Michela CasellaDepartment of Clinical, Special and Dental Sciences, Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Marche Polytechnic University, Ancona, Italy.
Claudio TondoDepartment of Clinical Electro-physiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Momina YazdaniDepartment of Cardiology, National Heart and Lung Institute and and MRC London Institute of Medical Sciences, London, United Kingdom.
James S WareDepartment of Cardiology, National Heart and Lung Institute and and MRC London Institute of Medical Sciences, London, United Kingdom.
Sanjay PrasadDepartment of Cardiology, National Heart and Lung Institute and and MRC London Institute of Medical Sciences, London, United Kingdom.
Leonardo CalòDepartment of Cardiology, Policlinico Casilino, Rome, Italy.
Eric SmithDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Adam HelmsDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Sophie HespeCentre for Population Genomics, Garvan Institute of Medical Research, and UNSW Sydney, Sydney, Australia.
Jodie InglesCentre for Population Genomics, Garvan Institute of Medical Research, and UNSW Sydney, Sydney, Australia.
Harikrishna TandriDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Flavie AderAPHP Sorbonne Université, DMU BioGem, UF de cardiogénétique et myogénétique moléculaire et cellulaire, Paris, France.
Luisa MestroniUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Arthur WildeDepartment of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Marco MerloDivision of Cardiology, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.
Estelle GandjbakhchAP-HP, IHU-ICAN, Groupe Hospitalier Pitié-Salpêtrière, Institut de Cardiologie, Sorbonne Université, Paris, France.
Hugh CalkinsDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Anneline S J M Te RieleDivision of Cardiology, Department of Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
J Peter van TintelenDepartment of Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
Perry ElliotDepartment of Cardiology, UCL Institute of Cardiovascular Science, London, United Kingdom.
Cynthia A JamesDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Funding

QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic CardiomyopathyR01HL116906 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MARCUS, FRANK I, MESTRONI, LUISA · 2013 to 2016
$9.2M
Molecular Epidemiology of Dilated CardiomyopathR01HL069071 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA · 2002 to 2005
$2.3M
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathyR01HL147064 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA, TAYLOR, MATTHEW R · 2020 to 2023
$2.1M
British Heart Foundation FS/CRTF/23/24448Medical Research Council MC_UP_1102/20NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NCATS NIH HHS UL1 TR003098NHLBI NIH HHS R01 HL069071NHLBI NIH HHS R01 HL116906NHLBI NIH HHS R01 HL147064
6 · The paper itself

Abstract

Background: Patients with likely pathogenic/pathogenic desmoplakin ( Objectives: The purpose of this study was to characterize arrhythmic outcomes and to test the performance of the recently validated ARVC risk calculator in patients with Methods: Results: Among 252 Conclusions:

Indexed as

ACMARVCdesmoplakinrisk stratification

Identifiers

PMID38938828
PMCPMC11198598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.